Correction: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
In the second-line treatment with gemcitabine plus nab-paclitaxel, the median PFS was 5.1 months (95% CI, 5.6 to 7.1), and the median OS was 8.6 months (95% CI, 7.3 to 10.0)." now reads: "In the second-line treatment with gemcitabine plus nab-paclitaxel, the median PFS was 5.1 months (95% CI, 4.6 to 6.0), and the median OS was 8.6 months (95% CI, 7.3 to 10.0)."
Authors
- Oğur Karhan (ORCID: https://orcid.org/0000-0002-7140-8957)
- Mustafa Özgür Arıcı (ORCID: https://orcid.org/0000-0001-9821-6368)
- Hacer Demir (ORCID: https://orcid.org/0000-0003-1235-9363)
- Ahmet Ufuk Kömüroğlu (ORCID: https://orcid.org/0000-0002-0371-9251)
- Talat Aykut (ORCID: https://orcid.org/0000-0002-9614-0651)
- Bilgin Demir (ORCID: https://orcid.org/0000-0003-4380-9419)
- Ali Alper Solmaz (ORCID: https://orcid.org/0000-0003-4696-1723)
- Yasin Sezgin (ORCID: https://orcid.org/0000-0003-4122-8389)
- Semiha Urvay (ORCID: https://orcid.org/0000-0002-0181-3842)
- Burcu Ulaş Kahya (ORCID: https://orcid.org/0000-0003-3661-9852)
- Musa Barış AYKAN
- Halis Yerlikaya (ORCID: https://orcid.org/0000-0003-4300-9972)
- İlkay Gültürk (ORCID: https://orcid.org/0000-0003-1998-3150)
- Mehmet Nuri Başer (ORCID: https://orcid.org/0000-0003-1809-5581)
- Muslih Ürün (ORCID: https://orcid.org/0000-0002-9883-3398)
- Mehmet Naci Aldemir (ORCID: https://orcid.org/0000-0002-7931-9078)
- Murat Araz (ORCID: https://orcid.org/0000-0002-4632-9501)
- Melike Özçelik (ORCID: https://orcid.org/0000-0003-0406-715X)
- Müge Sönmez
- Sezai Tunç (ORCID: https://orcid.org/0000-0002-4972-9367)
- Berrak Mermit Erçek (ORCID: https://orcid.org/0000-0003-1058-5500)
- Serdar İleri (ORCID: https://orcid.org/0000-0002-3739-3528)
- Hayati Arvas (ORCID: https://orcid.org/0000-0003-2215-5567)
- Hicran Anık (ORCID: https://orcid.org/0009-0001-7992-4008)
- Sedat Yıldız (ORCID: https://orcid.org/0000-0002-5531-8441)
- Mirmehdi Mehtıyev
- Esra Özen
- Sinem Akbaş
- Mehmet Erdem
- Yakup Ergün
- Mürsel sali
- Abudllah Sakin
- Zuhat Urakcı
- Mustafa Yıldırım
- Abdurrahman Bicer
- Mehmet Emin Kalender
- Nilüver Avcı
- Ali Alkan
- Nargiz Majidova
- Savaş Gökçek
- İbrahim Aydın
- Mustafa Gürbüz
Institutions
- Sakarya University (TR)
- Van Yüzüncü Yıl Üniversitesi (TR)
- Dicle University (TR)
- Bursa Uludağ Üni̇versi̇tesi̇ (TR)
- Izmir University (TR)
- Koç University (TR)
- Bilkent University (TR)
- Dokuz Eylül University (TR)
- Fatih University Medical Faculty Hospital (TR)
- Gülhane Askerî Tıp Akademisi (TR)
- Necmettin Erbakan University (TR)
- Sivas State Hospital (TR)
- Ankara Onkoloji Eğitim ve Araştırma Hastanesi (TR)
- Antalya Eğitim ve Araştırma Hastanesi (TR)
- Ümraniye Eğitim ve Araştırma Hastanesi (TR)
- Isparta University of Applied Sciences (TR)
- Education Training And Research (US)
- Şanlıurfa Mehmet Akif İnan Eğitim ve Araştırma Hastanesi (TR)
- Kayseri Eğitim ve Araştırma Hastanesi (TR)
- Diyarbakır Gazi Yaşargil Eğitim ve Araştırma Hastanesi (TR)
- Sanko University (TR)
- Istanbul Eye Hospital (TR)
- Afyon Kocatepe University (TR)
- Istanbul University (TR)
- Marmara University (TR)
- Adnan Menderes University (TR)
- Muğla University (TR)
- Harran University (TR)
- Gazi University (TR)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-04-03
- DOI
- https://doi.org/10.1038/s41598-026-47335-7
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00